>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:
  • HGSH +14.6%, FONR +8%, CNA +5.7%, FDC +4.5%, USAC +4.4%, PTN +1.1%, QSR +0.9%,L +0.6%, CRNT +0.5%
M&A news:
  • CSRA +31.9% (CSRA to be acquired by General Dynamics (GD) for $40.75/share)
  • CDK +3% (report that Carlyle Group (CG) could acquire CDK)
  • QCOM +2.5% ((Broadcom (AVGO) confirms it has signed committed financing agreements to fund its proposed acquisition of Qualcomm), )
  • GD +2.3%
  • FOXA +1.6% (Comcast (CMCSA) is considering reviving plan to acquire assets of FOXA despite Disney (DIS) deal, according to WSJ)
  • AVGO +1.3%
Select fan favorite names showing strength:
  • MU +2.7%, NFLX +2.2%, AMD +2.2%, SHPG +2.1%, AMZN +1.9%, NVDA +1.7%, CAT+1.7%, TWTR +1.7%, AAPL +1.5%, .
Select China related stocks trading higher:
  • YNDX +3.1%, MOMO +2.7%, WUBA +1.9%, BABA +1.8%, JD +1.6%
Other news:
  • MBVX +8.9% (announces positive data from expanded cohort in Phase 1 trial evealuating MVT-5873 in combination with First-Line chemotherapy in pancreatic cancer), DARE +23.7% (enters into license and collaboration agreement with Strategic Science and Technologies), #DIV/0! #DIV/0! RNN +13.2% (presents updated safety and efficacy data from the ongoing Phase 2a clinical trial of RX-3117 in advanced urothelial cancer), FOLD +6% (FDA has accepted the New Drug Application for the oral precision medicine migalastat HCl for the treatment of patients with Fabry disease), ZIOP +5.4% (announces data data demonstrating point-of-care (P-O-C) manufacturing of human T cells expressing chimeric antigen receptor (CAR) that persist and have an anti-tumor effect in preclinical models ), AVEO +5.2% (AVEO Oncology and EUSA Pharma announce encouraging preliminary results from Phase 2 Portion of the TiNivo Study), ICLK +4.8% (received the Advertising Agency Authorization Certificate from Baidu, Inc. (BIDU) for its native advertisements of news feed advertising in 2018), HMNY +4.1% (lowers price for MoviePass and Fandor bundled at $7.95 per month annual plan), TSLA +2.4% (Tencent (TCEHY) increases passive stake slightly to 8.35 mln shares from 8.17 mln shares), MMM +1.6% (CEO appears on Mad Money), PFPT +1% (CEO appears on Mad Money), .
Analyst comments:
  • EURN +6.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • CARA +5.7% (upgraded to Buy from Neutral at Janney)
  • WWE +3.3% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)
  • CSCO +2.5% (upgraded to Buy from Neutral at Nomura)
  • PHG +2.4% (upgraded to Buy from Hold at Berenberg)
  • VFC +2.3% (upgraded to Buy from Hold at Stifel)
  • SLB +2.3% (upgraded to Buy from Neutral at Griffin Securities)
  • HES +2.1% (upgraded to Neutral from Underperform at Credit Suisse)
  • WDAY +2.1% (upgraded to Buy at Needham)
  • BP +1.9% (upgraded to Buy from Hold at Societe Generale)
  • AXP +1.9% (upgraded to Buy at Nomura)
  • TEVA +1.5% (upgraded to Outperform from Neutral at Credit Suisse)
  • MOS +1.5% (upgraded to Neutral from Sector Underperform at CIBC)
  • PRU +1% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)